Humana Partners With Mark Cuban's Cost Plus Drugs to Lower Corporate Prescription Costs
Louisville, Monday, 31 August 2026.
Humana and Mark Cuban’s Cost Plus Drugs have partnered to reduce employer pharmacy costs by bypassing traditional markups, offering direct access to transparent, fixed-fee drug pricing.
Strategic Partnership Announcement
Humana Inc. (NYSE: HUM), through its CenterWell Pharmacy division, announced a strategic partnership with Mark Cuban’s Cost Plus Drugs Company to develop end-to-end prescription solutions for corporate employers [1]. The initiative, launched in late August 2026, aims to provide self-funded employer health plans with direct access to transparent drug pricing and direct-to-consumer pharmacy benefits, bypassing traditional pharmacy benefit manager markups [1]. This collaboration utilizes the SwiftyRx technology platform to automate benefit checks, streamline patient onboarding, and reduce prescription costs for enterprise leaders and decision-makers [1]. For enterprise leaders and decision-makers, this partnership underscores a major trend toward transparent drug pricing models aimed at reining in corporate healthcare expenses [1].
Financial Performance and Market Context
CenterWell Pharmacy reported $13 billion in revenue for 2025, an increase from $11.6 billion in 2024, representing a growth rate of 12.069 [1]. Humana is one of the largest administrators of Medicare Advantage, a U.S. government program that provides health care to older Americans via private insurers [2]. Humana plans are available in nearly 3,000 U.S. counties, the most of any Medicare Advantage provider, establishing a significant infrastructure for potential pharmacy benefit integration [2]. Additionally, the pharmacy began dispensing Eli Lilly obesity drugs for employer weight management programs earlier in 2026, indicating a broader strategy towards specialized employer solutions [1].
Pricing Models and Strategic Implications
Cost Plus Drugs, founded in 2022, offers 2,300 primarily generic medications at a price equal to acquisition cost plus a 15% fixed fee [1]. Humana plans to provide its employees enrolled in the associate benefit plan access to home delivery pharmacy services via the new platform, though no specific implementation date was provided for full deployment [1]. This move aligns with efforts to mitigate costs estimated by Mark Cuban as billions and billions of dollars in potential savings through transparent pricing structures [1]. The collaboration highlights a shift where large insurers leverage external transparent pricing models to manage corporate healthcare expenses more effectively [1].